Rowland Thomas Andrew 4

What Happened

• Rowland Thomas Andrew, Senior Vice President & Head — Established Brands at ANI Pharmaceuticals (ANIP), had shares withheld to satisfy tax obligations tied to the vesting of restricted stock. On Feb 12, 2026, 566 shares were withheld at $76.70 each (value $43,412). On Feb 14, 2026, 485 shares were withheld at $77.36 each (value $37,520). These were tax-withholdings (dispositions) rather than open-market sales.

Key Details

• Transaction dates & prices: Feb 12, 2026 — 566 shares @ $76.70; Feb 14, 2026 — 485 shares @ $77.36.
• Total withheld: 1,051 shares for a combined value of $80,932.
• Footnotes: F1/F2 state the withholdings were exempt under Rule 16(b)-3 in connection with the vesting of previously granted restricted stock (1,958 shares and 1,677 shares, respectively).
• Shares owned after the transactions: not specified in the provided filing.
• Filing timeliness: Report filed Feb 17, 2026. Given the transaction dates and the Feb 16 federal holiday (Presidents’ Day), the Feb 17 filing appears timely.

Context

• These transactions reflect routine tax-withholding on vested restricted stock (a cashless method of covering tax liabilities), not an open-market purchase or a voluntary sale that would more clearly signal insider sentiment. The Rule 16(b)-3 notation indicates these withholdings were processed as part of vesting and are treated as exempt for short-swing profit reporting purposes.